Individual Approach in Gynecological Cancer Brachytherapy
NCT: NCT03466957 · ACTIVE_NOT_RECRUITING
Brief Summary
MRI guided adaptive brachytherapy (BT) represents the gold standard in the treatment of gynecological cancers. Commercially available standard MRI compatible applicators for BT of gynecological cancers don't always allow for optimal target volume coverage. Three-dimensional (3D) printed technology enables versatile possibilities of improvement of standard applicators and development of novel applicators with better coverage of the target volume. The purpose of this study is to implement and assess 3D printing technology as an instrument for designing and manufacturing applicators for individualized BT of gynecological cancers.
Frequently Asked Questions
What is Individual Approach in Gynecological Cancer Brachytherapy?
Individual Approach in Gynecological Cancer Brachytherapy is a clinical trial registered under NCT03466957. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03466957?
The current status of NCT03466957 (Individual Approach in Gynecological Cancer Brachytherapy) is: ACTIVE_NOT_RECRUITING.
When did Individual Approach in Gynecological Cancer Brachytherapy start?
Individual Approach in Gynecological Cancer Brachytherapy started on 2016-05.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.